Cansinotech
Tianjin, CN · 2 known investors
CanSino Biologics is a Chinese biopharmaceutical company that develops, manufactures, and commercializes human vaccines for the prevention and treatment of infectious diseases, with seven marketed products and multiple vaccine candidates across five technology platforms. It serves domestic and global public health markets, including partnerships in South Asia for a 13-valent pneumococcal conjugate vaccine.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Cansinotech do?
- CanSino Biologics is a Chinese biopharmaceutical company that develops, manufactures, and commercializes human vaccines for the prevention and treatment of infectious diseases, with seven marketed products and multiple vaccine candidates across five technology platforms. It serves domestic and global public health markets, including partnerships in South Asia for a 13-valent pneumococcal conjugate vaccine.
- Who are Cansinotech's investors?
- Cansinotech's investors include Qiming Venture Partners, Fortune Venture Capital.
- Where is Cansinotech headquartered?
- Cansinotech is headquartered in Tianjin, CN.